Cognex CGNX is leaning into AI to widen what industrial machine vision can solve, and to make deployments simpler to repeat across sites. The next phase is less about a single end-market spike and ...

Cognex pushes AI-driven machine vision with new products and cloud tools as diversified end markets and a sales overhaul aim to expand adoption and double its customer base.

AI-enhanced vision systems automate medical device quality control, replacing manual inspection with flexible solutions.

However, the rise in Cognex’s stock price means its valuation is lofty with a price-to-earnings ratio exceeding 82. This suggests now is a good time for shareholders to sell, but it’s not the ideal ...

CEO Robert Willett told investors the industrial machine vision company is positioning for renewed growth across its end ...

On the reconciliation of selected items from GAAP to non-GAAP, line items like acquisition and integration costs or reorganization costs did not raise concerns. However, excess and obsolete inventory ...

Cognex Corporation (CGNX) 47th Annual Raymond James Institutional Investor Conference March 2, 2026 11:00 AM ESTCompany ParticipantsMatt Moschner ...

Corporate leaders often look to AI for breakthrough innovations, but a faster and more reliable payoff lies in using it to ...

NATICK, Mass., Feb. 10, 2026 /PRNewswire/ -- Cognex Corporation (NASDAQ: CGNX), the global technology leader in industrial machine vision, today announced that its Chief Financial Officer, Dennis Fehr ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in 1993 in Alexandria, VA., by brothers David and Tom ...